Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 633 results for "sun pharma advanced research"

SPARC shares surge 15%; m-cap up by Rs 1,685 cr
Rediff.com

Buy Sun Pharma Advanced: Mehraboon Irani

Mehraboon Irani of Nirmal Bang Securities is of the view that one may buy Sun Pharma Advanced Research Company. Money Control, 1 day ago
[x]  

32 images for sun pharma advanced research

India Infoline, 1 week ago
India Infoline, 1 week ago
India Infoline, 1 month ago
NDTV Profit, 4 months ago
India Infoline, 1 month ago
Business Standard, 1 month ago
Pharmafocus, 19 hours ago
India Infoline, 2 months ago
MSN News US, 1 week ago
Financial Express, 1 week ago
Business Standard

Pharma shares dip on profit bookings

Related to : Sun Pharma Advanced Research Company Ltd,Strides Arcolab Ltd,Natco Pharma Ltd,Ajanta Pharma Ltd Sun Pharma Advanced Research Company Ltd BSE 20 Mar 15 | 03:28 PM 470.70 -69.45 (-12.86%) NSE 20 Mar 15 | 03:20 PM 472.80 ...
 Smart Investor4 weeks ago Pharma shares extend fall; CNX Pharma index down 3%  Smart Investor1 day ago Markets remain flat; pharma shares gain  Smart Investor3 weeks ago Sun Pharma Advanced Research hit new high; zooms 200% in 2015  Smart Investor1 month ago
[x]  

Sun Pharma Advanced Research gains on BSE 200 inclusion

Sun Pharma Advanced Research Company gained as much 3.25 per cent in intraday trade on Friday as the company will be added to BSE 200 index, replacing ING Vysya Bank. The changes will be effective from April 16, BSE data showed. The inclusion ...
 Economic Times1 week ago Exit Sun Pharma Advanced Research: Kunal Bothra  Money Control3 weeks ago SPARC: More sparks to follow?  Business Standard India1 month ago SPARC gains on drug approval  Hindu Business Line1 month ago
[x]  
Moneycontrol.com

SPARC, Balkrishna to replace ING

Sun Pharma Advanced Research Co (SPARC) will replace ING Vysya Bank in the S&P BSE 200 index from April 16, the BSE said in a circular on Thursday. Balkrishna Industries will replace ING Vysya Bank in the BSE S&P 500 index. This follows the merger ...
 Hindu Business Line1 week ago BSE to drop ING Vysya Bank from BSE 200, BSE 500 indices  ZeeNews.com1 week ago

Research and Markets: Top 100 Asia Medical Devices/Technology/Supplies Companies 2015

Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and ...
 Morningstar.com1 week ago IPM registers Rs 7194 crores in February 2015  Financial Express2 weeks ago Top 100 Asia Medical Devices/Technology/Supplies Companies 2015  Individual.com1 week ago India's Sun Pharma research arm gets U.S. FDA nod for epilepsy therapy  Fierce Biotech Research1 month ago
[x]  
NDTV Profit

Why SPARC Shares Surged Over 40% in March

Shares of Sun Pharma Advanced Research Company (SPARC), a subsidiary of Sun Pharma Industries, rallied as much as 10 per cent to hit a new high of Rs 598 on Tuesday. Including today's gain, SPARC is up 42 per cent in the month of March. The stock ...
 NDTV Profit1 month ago SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 crore  Economic Times1 month ago SPARC shares settle with 5 pc gain; mcap up by Rs 440-cr  Business Standard1 month ago Sun Pharma, SPARC up 9-10%; antiepileptic drug gets FDA nod  Money Control1 month ago

Sun Pharma firm value rises by Rs 1,000 crore

Shares of Sun Pharma advanced research company (Sparc) on Thursday settled with gains of 10 per cent, adding Rs 1,014.53 crore to its market capitalisation, after the company received approval from the US health regulator for new drug application. In two ...
 Asian Age1 month ago

SPARC stock touches upper circuit limit; M-cap up by over Rs 1,000 cr

In two trading sessions, the company's stock has now jumped 15 per cent. Shares of Sun Pharma Advanced Research Company (SPARC ) on Thursday settled with gains of 10 per cent, adding Rs 1,014.53 crore to its market capitalisation, after the ...
 Business Today India1 month ago SPARC shares touch upper circuit; m-cap up by over Rs 1,000 cr  Business Standard1 month ago

SPARC's Elepsia XR tablets receives US FDA approval

Sun Pharma Advanced Research Company Ltd. (SPARC), a wholly owned subsidiary of Sun Pharmaceutical Industries, has received the US Food and Drug Administration (FDA) approval for its New Drug Application (NDA) for Elepsia XR (levetiracetam ...
 PharmaBiz1 month ago SPARC receives USFDA approval for 'ELEPSIA XR' extended-release tablets  Indian-Commodity1 month ago SPARC trades jubilantly on receiving USFDA approval for ELEPSIA XR extended-release tablets  Arihant Capital1 month ago SPARC shines on receiving USFDA approval for ELEPSIA XR extended-release tablets  Arihant Capital1 month ago
India Infoline

Sun Pharma Advanced Research stock hits 20% upper circuit

The stock has hit a high of Rs334 and a low of Rs277.
 India Infoline2 months ago SPARC to replace ING, stock ends flat  India Infoline1 week ago SPARC stock ends 7% lower  India Infoline1 month ago SPARC stock hits 10% upper circuit after FDA approval  India Infoline1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less